FDA Approves QALSODY (tofersen) for the Treatment of ALS in Adults who Have a Mutation in the SOD1 Gene

https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215887s000lbl.pdf?utm_medium=email&utm_source=govdelivery